June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Acute Ophthalmic Manifestations in Mycoplasma Induced Rash and Mucositis
Author Affiliations & Notes
  • Abdelrahman M. Elhusseiny
    Ophthalmology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Ramy Rashad
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Swapna S Shanbhag
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • James Chodosh
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Hajirah N. Saeed
    Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Abdelrahman Elhusseiny None; Ramy Rashad None; Swapna Shanbhag None; James Chodosh None; Hajirah Saeed None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 3946 – A0226. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Abdelrahman M. Elhusseiny, Ramy Rashad, Swapna S Shanbhag, James Chodosh, Hajirah N. Saeed; Acute Ophthalmic Manifestations in Mycoplasma Induced Rash and Mucositis. Invest. Ophthalmol. Vis. Sci. 2022;63(7):3946 – A0226.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The purpose of the current study is to demonstrate the prevalence of ocular complications in patients suffering with MIRM, an eruption clinically distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN).

Methods : In this retrospective observational study, we identified all patients in our hospital database who were diagnosed with MIRM. Diagnosis was confirmed by clinical information and a positive Mycoplasma pneumoniae serology. Only patients with available records with formal ophthalmology consults were included. Clinical and laboratory data were collected from our electronic medical record system.

Results : A total of 11 patients were included in our study. The average age was 22 ± 15.2 years, and the majority were male (63.6%). In all 22 eyes, the acute ocular findings were limited to conjunctival hyperemia (n=18, 81.8%), meibomitis (n=2, 9.1%), and conjunctival epithelial defects (n=1, 4.5%). None of the patients were treated with amniotic membrane transplantation in the acute phase. Three patients received follow-up eye examinations; none showed ocular complications.

Conclusions : Ocular complications from MIRM appear to be milder in comparison to ocular complications found in other bullous and inflammatory conditions such as SJS/TEN. Understanding the ocular sequelae of MIRM is important to better inform acute and chronic management.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×